![]() |
Safinamide
- 英文名称:Safinamide
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10846
- cas:133865-89-1
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B10846 |
用途 | 科研检测 |
英文名称 | Safinamide |
包装规格 | 1MG |
CAS编号 | 133865-89-1 |
别名 | Safinamide |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC;NMR (Conforms)
分子式:C17H19FN2O2
分子量:302.34
溶剂:DMSO (50 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):MAO-B inhibitor, Parkinson's therapeutic
Function / Pharmacology:A selective and reversible inhibitor of monoamine oxidase B (MAO-B, IC50=98 nM with greater than 100-fold selectivity over MAO-A.1 Displays anticonvulsant activity2 and protects against kainate-induced seizures and hippocampal neurodegeneration in rat models3. Reduces overactive glutamatergic signaling via use-dependent sodium channel blockade.4 A novel therapeutic for Parkinson’s disease with multiple modes of action.5 Effective as an add-on to dopamine agonist therapy in early Parkinson’s.6
分子式:C17H19FN2O2
分子量:302.34
溶剂:DMSO (50 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):MAO-B inhibitor, Parkinson's therapeutic
Function / Pharmacology:A selective and reversible inhibitor of monoamine oxidase B (MAO-B, IC50=98 nM with greater than 100-fold selectivity over MAO-A.1 Displays anticonvulsant activity2 and protects against kainate-induced seizures and hippocampal neurodegeneration in rat models3. Reduces overactive glutamatergic signaling via use-dependent sodium channel blockade.4 A novel therapeutic for Parkinson’s disease with multiple modes of action.5 Effective as an add-on to dopamine agonist therapy in early Parkinson’s.6